Conference call scheduled for August 12, 2008 at 1:30 p.m. (Pacific);
simultaneous webcast at http://www.adventrx.com
SAN DIEGO, Aug. 8 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals,
Inc. (Amex: ANX) today announced that it will host a conference call with
simultaneous webcast to discuss second quarter 2008 results on Tuesday,
August 12th, 2008 at 1:30 p.m. Pacific / 4:30 p.m. Eastern. Evan M. Levine,
Chief Executive Officer and President, and Mark N. K. Bagnall, Chief
Financial Officer and Executive Vice President, will host the conference
call.
The conference call may be accessed by dialing (888) 215-7027 for
domestic callers and (913) 312-0654 for international callers. The webcast
will be available live via the Internet by accessing ADVENTRX's website at
http://www.adventrx.com under "Investors". Replays of the webcast will be
available on ADVENTRX's website for 30 days and a phone replay will be
available through September 12, 2008 by dialing (888) 203-1112 and entering
the pass code 8240633.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on
in-licensing, developing and commercializing proprietary product candidates
primarily for the treatment of cancer and infectious disease. The Company
seeks to improve the performance and commercial potential of existing
treatments by addressing problems associated with these treatment regimens.
More information can be found on ADVENTRX's web site at
http://www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals, Inc.
 back to top
Related links:
http://www.adventrx.com
CONTACT:
Investors, Ioana C. Hone of ADVENTRX
Pharmaceuticals, Inc., +1-858-552-0866
|
